| First Author | Tare RS | Year | 2002 |
| Journal | Biochem Biophys Res Commun | Volume | 298 |
| Issue | 3 | Pages | 324-32 |
| PubMed ID | 12413943 | Mgi Jnum | J:80035 |
| Mgi Id | MGI:2429445 | Doi | 10.1016/s0006-291x(02)02456-7 |
| Citation | Tare RS, et al. (2002) Effects of targeted overexpression of pleiotrophin on postnatal bone development. Biochem Biophys Res Commun 298(3):324-32 |
| abstractText | Pleiotrophin (PTN) is an extracellular matrix-associated growth/differentiation factor that, in post-natal life, is found mainly in bone and brain. Bone development was investigated in ptn-overexpressing mice between 1 and 30 weeks. In transgenics and controls, PTN (and its receptor syndecan-3) was synthesized by osteoblasts and was present in striated muscle. ptn over-expression enhanced intramembranous bone formation and had multiple effects on long-term bone growth. The pubertal growth spurt did not take place in transgenic mice, in which the growth trajectory was steady and continuous until 25 weeks. By 30 weeks, transgenic and control mice were of the same size, but the calcium content/mg bone was approximately 10% higher in the transgenics. PTN was also localized in growth plate and articular chondrocytes, but only in transgenic mice. In these, synthesis of type I collagen by articular chondrocytes was observed, as well as an encroachment of subchondral bone into the articular cartilage. The results suggest that PTN has multiple roles during in vivo bone formation and remodeling, probably acting as a co-factor or accessory protein that modulates the effects of primary signaling molecules. |
